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PT 525 Clinical Medicine, Pharmacology and Exercise Prescription, 4 credits 
Spring 2003 
Syllabus for Clinical Medicine and Pharmacology, 3 credits 
Clinical Medicine and Pharmacology (75%) Exercise Prescription (25%) 
 
Class Schedule: 
Monday 2:10-3:00 SB 113 Exercise Prescription – J. Laskin 
Tuesday 10:10-12:00 SB 114 Clinical Medicine and Pharmacology – S. Fehrer 
Thursday 10:10-12:00 SB 114 Clinical Medicine and Pharmacology – S. Fehrer 
 
Instructor: Dr. Steve Fehrer 
  SB 107, 243-2429 
  sfehrer@selway.umt.edu 
 
Required Textbooks: 
Goodman and Synder. Differential Diagnosis in Physical Therapy, 3rd edition. Saunders 
2000. (GS) 
 
Goodman, Boissonnault, and Fuller. Pathology Implications for the Physical Therapist. 
Saunders 2003. (GB) 
 
Ciccone. Pharmacology in Rehabilitation 3rd edition. F.A. Davis 2002. (C) 
 
The listed readings are for enhancement of student understanding and clarification of 
material presented in class.  The course examinations will be based on material contained 
in the class presentations. 
 
Grading: 
Student performance evaluation will be based on two 50-point tests and a 50-point 
comprehensive final exam.  Grade distribution: A = 90-100%, B = 80-89%, C = 70-79%, 
<70% requires retake of test or final exam.  
Any evidence of cheating or plagiarism will result in failure of the course and possible 
remand to Academic Court for possible suspension or expulsion. 
 
Schedule: 
Tue 1/28 Immune – GS 390-433, GB 153-193, C 226-246  
1. Review of immune physiology, aging and the immune system, 
exercise immunology 
2. Adult and juvenile rheumatoid arthritis, pathogenesis, clinical 
manifestations, medical management 
 
Thur 1/30 Immune 
1. RA continued, pharmacologic agents (NSAIDs, 
 Glucocorticoids, DMARDs), PT management 
2. HIV/AIDS, clinical manifestations, medical and PT management; 
 Chronic fatigue syndrome 
 
 
 
Tue 2/4 Immune 
1. Hypersensitivity disorders 
2. Autoimmune diseases, systemic lupus erythematosus, fibromyalgia 
 
Thur 2/6 Immune/Transplantation 
  1.  Scleroderma, Guillain-Barre syndrome, differential diagnosis 
  2.  Transplantation types, post-transplant complications, exercise 
 
Tue 2/11 Transplantation – GB 772-820, C 633-649. 
1. Considerations based on type, HSCT, kidney, liver, heart, lung 
2. Immunomodulatory drugs 
 
Thur 2/13 No class   
 
Tue 2/18 Oncology – GS 334-389, GB 236-263, C 610-632. 
1. Classification of neoplasm, aging, metastases 
2. Medical management, exercise management 
 
Thur 2/20 10:10- Noon Oncology 
1. Cancer chemotherapy 
2. PT monitoring of the client with cancer 
 
Thur 2/20 1:10 – 3:00 Oncology 
1. Differential diagnosis considerations for various cancers 
2. Catch up 
 
Tue 2/25 Integumentary – GB 264-316 
1. Skin disease, aging, common skin disorders 
2. Common skin disorders, Herpes zoster, pressure ulcers 
 
Thur 2/27 Test 1; Integumentary 
  1.  Test 1 
  2.  Malignant neoplasms 
 
Tue 3/4 Integumentary; Endocrine 
1. Polymyositis and dermatomyositis, cold injuries, burns 
2. Endocrine pathology, aging, adrenal malfunction 
 
Thur 3/6 Endocrine – GS 287-333, GB317-366, C 433-529. 
1. Thyroid malfunction, parathyroid malfunction 
2. Diabetes Type 1 and 2, clinical manifestations  
 
Tue 3/11 Endocrine 
1. Medical management, pharmacological management 
2.  PT management of diabetes 
Thur 3/13 Endocrine 
  1.  Endocrine control of calcium homeostasis 
  2.  Hormonal contraception, androgen abuse 
 
Tue 3/18 Lymphatic – GB 477-508  
1. Lymphatic physiology, lymphedema 
2. Pathogenesis, clinical manifestations 
 
Thur 3/20 Lymphatic 
1. PT management 
2. Lipedema 
 
3/24-3/28 Spring Break 
 
Tue 4/1 Hematology – GS 181-196, GB 509-552, C 373-385, 388-391. 
1. Anemia, blood transfusion 
2. Neoplasm of blood cells 
 
Thur 4/3 Hematology 
1. Thrombocytopenia, sickle cell disease, hemophilia 
2. Thrombolytic drugs, antithrombotic drugs  
 
Tue 4/8 GI – GS 197-233, GB 628-703, C 386-388. 
1. Signs/symptoms disease, hernia, GERD, peptic ulcer disease 
2. Inflammatory bowel syndrome, adenocarcinoma 
 
Thur 4/10 Test 2; GI 
1. Test 2 
2. Appendicitis, peritonitis 
 
Tue 4/15 GI 
1. Hepatitis A B C, cholelithiasis 
2. Alcoholic liver disease/cirrhosis, pancreatitis 
 
Thur 4/17 GI 
1. Pancreatic cancer, differential diagnosis 
2. GI drugs – antiemetics, control gastric acidity, treat hyperlipidemia 
 
Tue 4/22 Renal – GS 234-259, GB 704-728 
1. Aging, urinary tract infections, chronic renal failure 
2. Chronic renal failure, renal dialysis 
 
Thur 4/24 Renal 
  1.  Renal calculi, urinary incontinence 
  2.  Differential diagnosis 
 
Tue 4/29 Infectious disease – GB 194-235, C 537-589. 
1. Signs/symptoms of infectious diseases, MRSA, isolation 
2. Nosocomial infections, pneumococcal infections 
 
Thur 5/1 Infectious disease 
1. Tuberculosis, lyme disease 
2. Antibacterial/antiviral drugs 
 
Tue 5/4 Pharmacology – C 110-122, 142-166. 
Anti-epileptics, anesthetics 
 
Thur 5/6 Review: GS 434-508 
Systemic origin of musculoskeletal pain  
 
Final exam Monday May 12 8:00-10:00 
 
Course Objectives:  
 
1=Knowledge 
2=Application 
3=Psychomotor 
4=Analysis, Synthesis, and Evaluation 
5=Affective 
 
A. Clinical decision Making and Examination 
1.1 Describe the process of hypothesis oriented algorithms within the context of the Nagi model of 
disability as it is used to guide physical therapy diagnosis, evaluation, and treatment. 
1.2 Differentiate between disease and illness, signs and symptoms, acute and chronic illness. 
1.3 Define differential diagnosis and state the role it plays in physical therapy practice. 
1.4 Describe the sources and types of pain. 
2.1 Recognize constitutional symptoms of systemic disease and utilize them in the completion of 
differential diagnosis. 
4.1 Engage in diagnostic process to establish differential diagnosis for patients across the lifespan based on 
evaluation of examination results and medical and psychological information. 
4.2 Determine the need for further examination or consultation by a physical therapist or for referral to 
another health care professional. 
 
B. Interviewing the patient 
1.1 Describe the appropriate interview process for patients receiving physical therapy. 
4.1 Using case studies and written examination, determine the appropriate interview questions and analyze 
resultant information for key indicators. 
4.2 Using case studies and written examination, determine from interview data when referral to other health 
care professionals is appropriate.  
 
C. Oncology 
1.1 Describe the common presenting symptoms of persons with the common forms of cancer.  
1.2 Describe the underlying pathology and theoretical causes of the common forms of cancer. 
1.3  Describe the course of progression of the common forms of cancer. 
1.4  Describe the typical patterns of medical management for clients with cancer. 
1.5  Describe lifestyle risk factors for the prevention of cancer. 
1.6 Describe the various chemotherapeutic agents and radiation therapy approaches used to manage 
cancer. 
4.1  Determine the impact of common medical management for cancer on physical therapy intervention for 
this client population. 
4.2 Using the typical referred pain patterns to determine if a client being seen for a possible 
neuromusculoskeletal problem should be referred to another health care professional. 
 
D. Immunological diseases 
1.1 Describe the common signs and symptoms of persons with various immunological disease states. 
1.2 Describe the epidemiology, diagnosis and prognosis for rheumatoid arthritis and osteoarthritis. 
1.3 Describe the appropriate physical therapy management of these clients, considering pain reduction, 
deformity prevention, exercise prescription, and function preservation. 
1.4 Describe the major differences between osteo- and rheumatoid arthritis. 
1.5 Describe the medications commonly utilized to manage arthritis. 
1.6 Describe the common forms of medical intervention for these disorders. 
1.7 Describe the underlying pathology and theoretical causes. 
1.8 Describe lifestyle risk factors for acquiring AIDS. 
4.1 Using a case study, determine the type of immunological condition and appropriate physical therapy 
intervention. 
 
E. Endocrine disorders 
1.1 Describe the common signs/symptoms of persons with endocrine disorders. 
1.2 Describe the common forms of medical intervention for these disorders. 
1.3 Describe the underlying pathologies for diabetes mellitus. 
1.4 Describe the lifestyle risk factors for the prevention of type II diabetes. 
1.5 Describe the pharmacological interventions commonly used to manage diabetes. 
3.1  Demonstrate how to test blood glucose. 
4.1 Determine the implications of medical management on physical therapy interventions. 
 
F. Integumentary disorders 
1.1 Describe the common signs/symptoms of persons with these disorders. 
1.2 Describe the common forms of medical intervention for these disorders. 
2.1  Demonstrate how to monitor a client’s skin to assess for presence of skin cancer. 
2.2  Demonstrate how to monitor a client’s skin to assess for presence of pressure ulcers. 
4.1 Determine the implications of medical management on physical therapy interventions. 
 
G. Gastrointestinal and urinary tract disorders 
1.1 Describe the common signs/symptoms of persons with these disorders. 
1.2 Describe the common forms of medical intervention for these disorders. 
1.3 Describe the underlying pathologies for these disorders. 
1.4 Describe the referred pain patterns for these disorders. 
2.1  Explain how the clinician protects self from hepatitis infection. 
4.1 Determine the implications of medical management on physical therapy interventions. 
 
H. Hematology and lymphatic disorders 
1.1 Describe the common signs/symptoms of persons with these disorders. 
1.2 Describe the common forms of medical intervention for these disorders. 
1.3 Describe the medications used to alter blood clotting. 
4.1 Determine the implications of medical management on physical therapy interventions. 
 
I. Transplantation 
1.1 Describe the common transplantation procedures. 
1.2 Describe the potential complications that a transplant patient may encounter. 
4.1 Determine the implications of medical management on physical therapy interventions. 
 
J. Infectious disease disorders 
1.1 Describe the common signs/symptoms of persons with theses disorders. 
1.2 Describe the common forms of medical intervention for these disorders. 
1.3 Describe the medications used to treat these disorders. 
1.4  Explain role of physical therapy in the delivery of services with clients in isolation. 
1.5 Describe the PPD test and the significance of a positive result. 
1.6 Explain how a therapist protects him/herself from TB exposure. 
4.1 Determine the implications of medical management on physical therapy interventions. 
  
K. Pharmacology 
1.1 Describe the normal mechanisms of drug absorption, distribution, metabolism and excretion for 
prescription and over-the-counter drugs. 
1.2 Describe how the processes described in 1.1 are altered by disease state and age. 
1.3  Match common drug names to appropriate drug categories. 
1.4  Describe common side effects of  drug categories, especially those affecting physical therapy 
interventions. 
2.1 Explain why physical therapists cannot prescribe drugs and should not advise patients/clients to take a 
particular drug.  
2.2 Demonstrate how to effectively communicate with a physician about particular medication(s) your 
client is taking. 
4.1 Given a patient history, determine the effects of a drug regimen on physical therapy treatment. 
4.2 Determine when signs/symptoms indicate the need for a referral to a pharmacist or physician. 
 
 
 
